Gilead Sciences
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Gilead Sciences
RECRUITINGPhase 1NCT04617522
Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment
The goals of this clinical study are to learn more about the safety and dosing of the study drug, sacituzumab govitecan-hziy, in participants with solid tumors and moderate liver...
Sponsor: Gilead SciencesEnrolling: 3013 locations
Advanced or Metastatic Solid TumorLiver Failure
RECRUITINGPhase 2NCT06029972
Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
The goal of this study is to learn if tilpisertib fosmecarbil (formerly known as GS-5290) is effective and safe in treating participants with moderate to severe ulcerative...
Sponsor: Gilead SciencesEnrolling: 17620 locations
Ulcerative Colitis
RECRUITINGPhase 2NCT02932150
Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection
The goals of this clinical study are to compare the effectiveness, safety and tolerability of study drug, tenofovir alafenamide (TAF), versus placebo in teens and children with...
Sponsor: Gilead SciencesEnrolling: 15020 locations
Chronic Hepatitis B